For the past few months, IOI has been working to support the team at bioRxiv & medRxiv, two leading open preprint offerings serving the scientific and medical community globally. This partnership, made possible through the support of Cold Spring Harbor Laboratory (CSHL), aims to support the two entities in diversifying their funding and revenue sources to ensure long-term sustainability.
IOI’s Kaitlin Thaney and Katherine Skinner recently sat down with John Inglis and Richard Sever to hear more about their experience in building the future of bioRxiv and medRxiv and to learn about their next steps.
Over the past year, you’ve been working towards revenue diversification for bioRxiv and medRxiv. What do you see as the main goal of this work, and why is it so timely to undertake it now?
We’ve had invaluable support for the servers from Cold Spring Harbor Laboratory since bioRxiv began 10 years ago, and major funding from the Chan Zuckerberg Initiative (CZI) for bioRxiv since 2017 and for medRxiv since 2020. We’re delighted that the volume of posted preprints on both servers is continuing to grow but the reality is that with such growth comes increased costs. So as the servers become more and more established as essential pieces of communication infrastructure, it makes sense for them to be supported financially by a diversity of stakeholders in the community, to enable long-term viability and stability. So we are asking a variety of other organizations to help ensure the servers have the resources they need to continue becoming ever more successful. These include other science funders that share CZI’s commitment to open science. For example, we were fortunate recently to receive a major gift from the Sergey Brin Family Foundation. But we’re also reaching out to research institutions worldwide. Thousands of them have scientific staff who’ve posted preprints to our servers and use them to learn about work that scientists elsewhere have done. These researchers regard the servers as immensely valuable. Recognizing that, several academic institutions have offered financial support, including Stanford, MIT, Caltech, CNRS, Fred Hutchinson Cancer Center, Imperial College, University of Washington, and Vrije Universiteit Amsterdam. We are just at the beginning of these diversification efforts and have been encouraged by these initial responses to believe there are many more institutions that will recognize the value these free, not-for-profit services provide and will be willing to lend their support.
You’ve had an immense growth curve in your first decade of work in preprints, building technical, operational, and moderation structures that supported your initial scaling from a pilot initiative to a crucial platform for scientific research (e.g., COVID-19). Looking back on that success, what advice do you have for projects hoping to make this same leap into full production?
Several things. Be very clear with yourself about the value proposition of your project to the target audience. Then find a way of describing it simply and without hype. Consult people with relevant experience (we got a lot of advice in advance from the arXiv team, for example) but be prepared to adapt what you learn for your purposes. Seek out supporters for your vision in your community and co-opt them as allies and advocates: much more than marketing dollars, they are your greatest resource for spreading the word and an invaluable source of advice and encouragement. Accept that you may have to build something that demonstrates your vision even though you have no additional money or people to do it with. Then when you can start building a team, hire people with skills you don’t have who are as passionate and dedicated to achieving success as you are.
As you plan towards your next decade of growth, what role are you positioning bioRxiv and medRxiv to play?
Very simply, we want the servers to continue their mission of enabling rapid, open, and free sharing of biomedical research findings and engaging progressively more of the world’s scientists in using the services. But in addition we also want the servers to be a platform for experiments, innovation, and improvements in how research results are communicated, discovered, evaluated, and recognized. We’ve made a start on this but there is much more to be done.
As part of your maturation, what kinds of organizational and governance needs are you experiencing and how are you addressing those?
We have a fantastic team of colleagues who have coped in amazing ways with all the growth in content volume on both servers in the past five years, including the deluge of pandemic-related science that was communicated in real time as COVID-19 advanced worldwide. Continued scaling will put more and more pressure on our largely human-centric manuscript screening processes so we are looking for automated tools that can be adapted to assist with this. We also need more engagement with research institutions, not just for financial support but to understand how they are beginning to deal with preprints as important outputs of their research staff. We are also connecting with science funders who are interested in moving preprints to a more central place in the communication strategies of their grantees. And we are also aware of enormous support within the research community itself and intend to find ways of giving that community a voice in the governance and management of the servers.
What advice would you give other infrastructure providers who are interested in IOI’s Strategic Support offering?
IOI is unique in the breadth of its experience and the domain expertise of its executive team. They also have a remarkable range of connections among funding organizations. The needs assessment IOI did on behalf of bioRxiv and medRxiv was very important in helping us set new strategies for diversifying our financial support. We have also received valuable advice from IOI’s team as we consider the servers’ organizational evolution.
What news can we watch for from bioRxiv and medRxiv?
Organizational evolution! In the next few months we will have exciting news to share about changes in the management of the servers that will increase their capacity to fulfill the mission and augment the expertise of their talented team. bioRxiv’s second decade and medRxiv’s second half-decade are filled with promise.
This post is part of our “Infrastructure Spotlight” series. To stay updated on posts from this series and more from Invest in Open Infrastructure, please sign up for our newsletter. Interested in IOI’s Strategic Support services to further research infrastructure health, sustainability, and growth on these topics or related areas of work? Get in touch!